Medical Condition News

RSS

Alizé Pharma obtains exclusive worldwide rights to develop new therapy for bone diseases

Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, today announces that it has acquired exclusive worldwide rights to develop and commercialize a new family of peptides with bone anabolic properties.

4 Dec 2014

PulmoFlow's nebulized drug and device combination gets FDA approval for cystic fibrosis

On Tuesday, the FDA granted final approval of PulmoFlow, Inc.'s New Drug Application for Kitabis Pak – a co-packaging of generic tobramycin inhalation solution with a PARI LC PLUS Nebulizer. This is the first nebulized drug and device combination to be approved for patients with cystic fibrosis.

3 Dec 2014

New NHLBI grant to support development of prevention strategies for deadly heart condition

One of medicine's most prominent experts in sudden cardiac arrest has received a new $2.36 million grant to study how to better predict the deadly heart condition that kills an estimated 300,000 Americans each year.

3 Dec 2014

Scientists report new approach to defeating asthma by targeting allergen

Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists are reporting a new approach to defeating asthma by targeting the trigger -- the allergen -- before it can spark an attack. They describe their new compound, which they tested on rats, in ACS' Journal of Medicinal Chemistry.

3 Dec 2014

Ten facts about Alzheimer's disease

Dr. Daniel Thomas will be conducting a ground-breaking study to determine if cognitive decline due to memory-destroying Alzheimer's disease can begin to be reversed in 90 days by combating the root causes using an innovative combination of diet, exercise, vitamin supplements, hormone therapy, and intravenous nutrition.

3 Dec 2014

Northwestern Medicine neurosurgeons use new adaptive hybrid surgery technology to treat brain tumor

It started with numbness on the left side of his face. A few months later, Steve Mores couldn't feel his tongue or chew on the left side of his mouth. TV commercials featuring food or even being in a grocery store made him nauseous. A long time drummer in a popular band, Mores lost 30 pounds and had to find a replacement.

3 Dec 2014

Researchers use MRI techniques to study consequences of anorexia nervosa on brain structure

Researchers from the Translational Developmental Neuroscience Lab led by Professor Stefan Ehrlich at the Department of Child and Adolescent Psychiatry and Psychotherapy of the University Hospital Carl Gustav Carus at the TU Dresden (Faculty of Medicine) used state-of-the-art magnetic resonance imaging (MRI) techniques to investigate the consequences of anorexia nervosa on brain structure.

3 Dec 2014

New study describes revolutionary novel device that has potential to treat eye diseases

The aging process affects everything from cardiovascular function to memory to sexuality. Most worrisome for many, however, is the potential loss of eyesight due to retinal degeneration.

3 Dec 2014

Blue light can knock circadian rhythms off-kilter, study finds

A study funded by the National Institutes of Health is unraveling the mystery of how blue light from residential and commercial lighting, electronic devices, outdoor lights and billboards can throw off-kilter the natural body clock of humans, plants and animals, leading to disease.

3 Dec 2014

Unique challenges in providing psychotherapy to people with ASD and gender dysphoria

The challenges in providing psychotherapy to individuals with autism spectrum disorders (ASD) who also are struggling with their gender identity are explored in two case studies of high-functioning persons with diagnoses of ASD and gender dysphoria (GD).

3 Dec 2014

SAFit-ligands provide foundation for novel treatment of stress-related psychiatric disorders

The FK506-binding protein 51 (FKBP51) is an established risk factor for stress-related psychiatric disorders such as major depression. Drug discovery for FKBP51 has been hampered by the inability to pharmacologically differentiate against the very similar functional counterplayer FKBP52.

3 Dec 2014

Study finds that cancer cells may be susceptible to metabolic stress

Research at the University of Adelaide has discovered cancer cells may be particularly susceptible to metabolic stress - opening the way for new targeted therapy that won't harm normal cells.

3 Dec 2014

Researchers remake brain and gut stem cells to study potential therapies for fatal diseases

Research scientists have developed a novel method to re-create brain and intestinal stem cells from patients who died decades ago, using DNA from stored blood samples to study the potential causes of debilitating illnesses such as inflammatory bowel disease.

3 Dec 2014

Abnormal activation of cell death pathways may lead to inflammatory skin diseases

Inflammatory skin diseases such as psoriasis may result from abnormal activation of cell death pathways previously believed to suppress inflammation, a surprise finding that could help to develop new ways of treating these diseases.

3 Dec 2014

Experts report three key topics that may make difference in the battle against Alzheimer's disease

Detection, prevention, and preclinical treatment are three key areas that may make a difference in the battle to reduce the rapid rise of new Alzheimer's disease (AD) cases every year. These three topics are the focus of an important new supplement to the Journal of Alzheimer's Disease.

3 Dec 2014

U-M startup company Imbio gets FDA approval to market Lung Density Analysis for COPD

A technology that started in a University of Michigan Medical School lab may soon help lung disease patients around the world breathe a little easier, by helping their doctors make a clearer diagnosis and more individualized treatment plan.

3 Dec 2014

Elevated anxious temperament associated with neuropeptide Y receptors

Persistent anxiety is one of the most common and distressing symptoms compromising mental health. Most of the research on the neurobiology of anxiety has focused on the generation of increased anxiety, i.e., the processes that "turn on" anxiety.

3 Dec 2014

University of Chicago collaborates with NCI to set up Genomic Data Commons

The University of Chicago is collaborating with the National Cancer Institute to establish the nation's most comprehensive computational facility that stores and harmonizes cancer genomic data generated through NCI-funded research programs.

3 Dec 2014

UNM Cancer Center program to help new scientists learn nuances of conducting science

create a set of systems to track people, projects and money. But scientists' formal training doesn't always include business classes. To bridge this gap, Michelle Ozbun, PhD, at the University of New Mexico Cancer Center, is improving a program that helps new scientists learn nuances of conducting science.

3 Dec 2014

Meniscal surgery may increase risk of osteoarthritis, cartilage loss

A popular surgery to repair meniscal tears may increase the risk of osteoarthritis and cartilage loss in some patients, according to research presented today at the annual meeting of the Radiological Society of North America. The findings show that the decision for surgery requires careful consideration in order to avoid accelerated disease onset, researchers said.

3 Dec 2014

Medical Condition News

Alizé Pharma obtains exclusive worldwide rights to develop new therapy for bone diseases

PulmoFlow's nebulized drug and device combination gets FDA approval for cystic fibrosis

New NHLBI grant to support development of prevention strategies for deadly heart condition

Scientists report new approach to defeating asthma by targeting allergen

Ten facts about Alzheimer's disease

Northwestern Medicine neurosurgeons use new adaptive hybrid surgery technology to treat brain tumor

Researchers use MRI techniques to study consequences of anorexia nervosa on brain structure

New study describes revolutionary novel device that has potential to treat eye diseases

Blue light can knock circadian rhythms off-kilter, study finds

Unique challenges in providing psychotherapy to people with ASD and gender dysphoria

SAFit-ligands provide foundation for novel treatment of stress-related psychiatric disorders

Study finds that cancer cells may be susceptible to metabolic stress

Researchers remake brain and gut stem cells to study potential therapies for fatal diseases

Abnormal activation of cell death pathways may lead to inflammatory skin diseases

Experts report three key topics that may make difference in the battle against Alzheimer's disease

U-M startup company Imbio gets FDA approval to market Lung Density Analysis for COPD

Elevated anxious temperament associated with neuropeptide Y receptors

University of Chicago collaborates with NCI to set up Genomic Data Commons

UNM Cancer Center program to help new scientists learn nuances of conducting science

Meniscal surgery may increase risk of osteoarthritis, cartilage loss

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News